←BACK

 

Article

 

Dextran-containing nanocarriers significantly promote greater anchorage dependent cell growth and density compared to microcarriers

 

Edmund, Anton1, 2, Kambalapally, Swetha 1, 2, Wilson, Thomas 2, and R J Nicolosi2*

 

1 Biomedical Engineering and Biotechnology PhD Program

2 Centers for Health and Disease Research, Division of Nanomedicine University of Massachusetts Lowell 3 Solomont way, Lowell, MA 01854

 

* Corresponding author. Email: aedmund@hotmail.com

 

Citation: E. Anton, et al. Dextran-containing nanocarriers significantly promote greater anchorage dependent cell growth and density compared to microcarriers. Nano Biomed. Eng. 2012, 4(1), 29-34.

DOI: 10.5101/nbe.v4i1.p29-34

 

Abstract

Microcarriers containing cellulose-derived materials have been successfully applied to enhance the growth of anchorage-dependent cells maintained especially in bioreactors. By replacing microcarriers with nanocarriers containing dextran, we hypothesized that the density of the anchorage-dependent cells would rise dramatically because the decreased particle size and associated enhancement in surface to volume ratios of nanoparticles contained within the nanoemulsion-based nanocarriers would increase the number of dextran molecules for the anchorage-dependent cells to attach to. Our studies utilized self-assembly nanoemulsions (SANE) formed by a modified phase inversion temperature (PIT) process to produce dextran oil and surfactant-containing nanocarriers having mean particle sizes of 26 nm compared to microcarriers which were greater than 6000 nm. Our results demonstrated that dextran-containing nanocarriers allowed up to 10 fold greater cell density,12% more media lactate concentration, 83% higher cell lysate protein and 59% greater glucose concentration, used as a measure of polymer levels in the nanocarriers compared to microcarriers. In conclusion, nanocarriers with increased numbers of dextran molecules, developed in these studies may be useful to further increase the production of anchorage-dependent animal cell-derived products or production of mass cell growth for other applications..

 

Keywords: Nanocarriers, Nanoemulsions, Nanoparticles, Microcarriers, Cell culture, CHO;

 

1.                Introduction

The utilization of mass cultures of animal cell lines is fundamental to the manufacture of enzymes and many products of biotechnology (1). The biologics produced by recombinant DNA (rDNA) technology in animal cell cultures include, but are not limited to proteins such as enzymes, synthetic hormones, immuno-biologicals, and anticancer agents. Although many simpler proteins can be produced using rDNA technology in bacterial cultures, more complex proteins that are glycosylated or carbohydrate-modified, currently must be produced by anchorage-dependent animal cells. They are usually manufactured in bioreactor systems that require cell adhering surfaces such as tissue culture plastic (1). Microcarrier technology has been applied to anchorage-dependent cells for the production of a variety of biologic products since these microcarriers have the advantage of [a] increasing production capacity [b] enhancing separation of cells from secreted end products [c] protecting against physical stress [d] reducing the required volume of cell culture media [e] reducing labor intensity and [f] lowering risk of contamination (2). Moreover, the bioreactor operation requirements are virtually identical to those for typical suspension cultures in fermentors except that the upper limit for agitation is lower for mixing nutrients without disturbing the cells. Operating modes such as batch, fed-batch, and perfusions are routinely used in microcarrier systems. Microcarrier technology, developed over the past three decades still remains the cornerstone for cell culture production of biologics due to its versatility in supporting the growth of a variety of anchorage-dependent cells and therefore will continue to insure its unique place in bio-processing (3). However, that having been said, there are opportunities to improve the efficiency of anchorage-dependent cell production of biologics such as, but not limited to the utilization of nanosphere-containing carrier systems. In porous cellulose that characterizes the cellulose-based and microcarrier-dependent cell culture systems, cells adhere on the surface and are entrapped in the pores (100–200 µM in diameter) of the cellulose of the spherical microcarriers and are cultured in stirred suspension bioreactors (3). However, shear stress exerted on the surface of the microcarriers has been reported to damage cells and/or decrease their viability in vigorously stirred suspension bioreactors (4). In cell aggregate cultures, anchorage-dependent cells form spherical aggregates and grow in suspensions (5) and although cells within aggregates could be protected from the shear stress in stirred suspension bioreactors, not all types of cells are induced to form cell aggregates and, moreover, aggregate formation rate is slow (6). Taken together, these disadvantages in current cell culture systems for the production of biologics suggest a need for a more efficient technology such as, but not necessarily limited to the use of dextran-containing nanocarriers in combination with anchorage-dependent cells. Additionally, it is well established that during the initial phase purification of the harvested biologic from the production bioreactor, capture purification is the first critical step of protein purification. Speed and capacity are the primary objects of this step (7) and despite more recently-developed microcarrier systems being formulated with lower clogging effect, varying degrees of clogging still occurs during this filtration process which can cause unwanted production delay, labor and product lost (8). By virtue of their smaller particle size, the proposed use of nanocarriers will pass through the filtration process during the capture phase (8), which can be subsequently filtered out later using commercially-available nano filters. Earlier preparations of microcarriers were composed of dextran because it had been previously shown that the addition of the glucose polymer Dextran to the microcarrier lowered charge density and led to improvement of microcarrier technology (9), for example, dextran-derived materials have been widely used in biologics application because they [a] provide a matrix for anchorage-dependent cells to attach to [b] have a simple glucose backbone raising the possibility that functional groups can be attached for targeting purposes [c] have a neutral pH [d] are water soluble [e] are biodegradable, [f] demonstrate ease of removal by simple filtration and [g] are biocompatible (10) . Thus, dextran was also included in our nanocarrier system. More recently, microcarriers are being prepared with a very porous cellulose polymer (11) which presumably enhances the entrapment of cells adhering to the microcarrier. Self-assembling nanoemulsions (SANE) using phase inversion temperature (PIT) technology (patent pending) was the system used to prepare the nanosphere-containing dextran nanocarriers in this communication. These nanoemulsions contained nanocarriers in an oil-water-surfactant interphase having very small particle sizes (@ 25 nm). This preparation was modified to include the polymer dextran as a potential mechanism(s) for increased adherence of cells to the nanocarrier.

 

2. Method and Materials

2.1 Nanoemulsion preparation using a modified Phase Inversion Temperature (PIT) Method:

The components of the nanoemulsion produced [patent-pending] were a vegetable oil which, for this application was rice bran oil (RBO) (Tsuno, Japan), the surfactant Solutol HS 15 (BASF, Ludwigshafen, Germany) and deionized water (Millie Q, Bedford, MA). The RBO (0.5 g) was added to a 50 mL autoclaved beaker along with 2.5g of the surfactant Solutol, 75 mg Dextran (Mol Wt Mr~1500 from Sigma Cat. 31394, Sigma, Saint Louis, MO) and combined with up to 25 mL of deionized water with gentle mixing. The PIT (also referred to as HLB (Hydrophile –Lipophile temperature) varies depending upon the HLB number (Hydrophile –Lipophile balance) of the surfactant. PIT rises with increase in HLB number. The mixture was heated and stirred for 5 min @ 50-60°C until the three components form a homogeneous mixture. The distilled water (total volume = 23 mL) was added while the mixture was stirring at @ 60°C to form an O/W emulsion. During heating, when the PIT (or HLB temperature) of the system was reached (65-70°C, phase inversion zone), the surfactant was in equilibrium with the oil and water phases. Heating and stirring was continued beyond the PIT up to 80°C inverting to a W/O emulsion. The emulsion was subsequently cooled to room temperature to obtain an O/W emulsion. The particle sizes of the nanoemulsions were determined by dynamic laser light scattering using the Malvern Zetasizer-S (Malvern Instruments Inc., Southborough, MA). The range of particle sizes which can be measured by the Zetasizer is from 0.6 to 6000 nm. The measurement of zeta (ξ) potential is based on the following principle: the colloidal particles that constitute the nanocarriers dispersed in rice bran oil and Solutol solutions are electrically charged due to their ionic characteristics and dipolar attributes. Each particle dispersed in the solution is measured using the Malvern Zetasizer Nano series Zen 3600 (Malvern Instruments Ltd., Enigma Business Park, Grovewood Road, Malvern, WorcestershireWR14 1XZ, U.K.)

 

2.2 Cell culture and preparation for inoculation

Chinese hamster ovarian (CHO) cells were maintained in a disposable Petri Dish with 25 mL (minimum essential medium) MEM culture medium supplemented with glucose (2.0 g/L) and 10% fetal bovine serum in a 5% CO2:95% O2 incubator at 37ºC. The cell passage was carried out at 80–90% confluency at a 1:5 ratio with 0.15% trypsin in Ca2Cl, Mg2Cl-free phosphate-buffered solution (PBS).The cells were counted using a hemacytometer before inoculation. Two sterilized 250 mL spinner flasks were prepared for cultivation and each was filled with 100 mL MEM plus 25 mL of freshly prepared nanocarriers, or microcarriers (230 µM particle size of Cytopore 2®). Microcarriers were washed with PBS, and a hydration step was performed to remove any air trapped from the microcarrier before being added to the spinner flask. Each flask was placed on a stir plate and inoculated with 2mL CHO cells and maintained in a 5% CO2:95% O2 incubator at 37º C. Stirring was set to minimum speed for agitation. The duration of the growth studies was at least 4-5 days. Samples were taken from each spinner flask for microscopic examination and growth determination. The cells were counted using a Hemacytometer before inoculation.

 

2.3 Cell density, media lactate, cellular protein and carrier glucose measurements as an indicator of polymer concentration

Numbers of viable cells were obtained with a light microscope using a hemacytometer to determining each culture’s cell density. Media lactate levels were measured by ABCHEM lactate assay kits (Cambridge, MA) to estimate metabolic production of lactate. For measuring cellular protein concentrations using the Bradford assay (12), 2 mL of culture media was taken from the spinner flask, centrifuged at 1000 rpm for 10 min, washed 2 times with ice cold phosphate buffered saline [PBS], and centrifuged between washes. Lysis buffer was added to cells; the cell suspension transferred into a centrifuge tube and allowed to incubate for 15 minutes in the cold room to completely lyse the cells. The lysate was centrifuged at 1000 rpm for 15 minutes and the supernatant immediately transferred to a fresh centrifuge tube. The pellet was discarded. The supernatant [cell lysate] was diluted up to 10x for measurement of the protein concentration. Glucose concentration as a measure of the glucose content of the polymers dextran and cellulose in the nano and microcarriers, respectively, was determined using the Sigma GAGO-20 glucose kits (Sigma, Saint Louis, MO).

 

2.4 Statistical analysis

Data were obtained from analyses of triplicate samples and expressed as the mean + standard deviation (SD). One way ANOVA analysis followed by Tukey’s “t” test was done on these triplicate groups. A value of p< 0.05 was considered to be statistically significant.

 

3. Results

3.1 Particle size and zeta potential of the nanoemulsions of the dextran-based nanocarrier

As shown in Figure 1a, particle size Z-average was 25.15 nm for nanocarriers composed of 75 mg Dextran, 0.5 g RBO, 2.5g Solutol and 22 mL water. The polydisperse index (PDI) was 0.312. As shown in figure 1B, results of Zeta potential for nanocarrier indicated -3.62 mV. Microcarrier particle sizes and PDI [not shown] were beyond the limits of determination by the Malvern Zetasizer-S.

 

 

Figure 1 a: Particle size analysis of nanocarriers showing the Z-average size distribution of the particle. As shown, nanoemulsion technique can be used to formulate in the range of 25 - 30nm and the PDI was 0.192. b: Particle size analysis of nanocarriers showing the zeta potential of nanospheres. As shown, particles have a mean of -3.62 mV zeta potential.

 

3.2 Cell density, media lactate, nanocarrier glucose and cell protein lysate concentration.

3.21 Cell density

Measurements of viable cell counts [Figure 2], showed that although viable cell counts on day 5 of culture were higher than baseline (day 1of culture) for both the nano and microcarrier-containing CHO cell cultures, viable cell counts, in CHO cells exposed to nanocarrier [22.3 X106 ± 1.0/mL] had 10 times higher cell density compared to microcarrier-containing cultures [2.247 X 106 ± 0.5 /mL] [p<0.0035].

 

3.2.2Media lactate measurements

On the 3rd day of culture, media lactate levels from CHO cell cultures exposed to nanocarriers were 1.0927+ 0.033 mg/mL, which were 12% higher [p<0.0037] compared to media from CHO cells exposed to microcarriers 0.9195 + 047 mg/mL.

 

3.2.3 Cell lysate protein concentrations

Comparisons between the 2nd and 4th day of culture, showed the protein content of CHO cells exposed to the microcarriers increased from 24.9 + 5.4 (ng/ml) to 56.8 + 3.1(ng/ml) (93%; p < 0.05) while CHO cultures exposed to nanocarriers increased from 45.6 + 4.2 (ng/ml) to 111.3 + 6.4 (ng/ml) (144%; p < 0.05). In addition, comparisons between the micro and nanocarriers, showed that at 2nd day of culture protein concentration of lysates from cells exposed to nanocarriers (45.6 + 4.2) was 83% greater than microcarriers (24.9 + 5.4-give units; p<0.006). Similarly, at 4th day of culture, protein concentration of lysates from cells exposed to nanocarriers (111.3 + 6.4) was 96% greater than microcarriers (56.8 + 3.2) (ng/ml) (p<0.0002).

 

Figure 2: Differences in viable cell densities between nanocarriers and microcarrier-containing cell cultures maintained for up to 5 days. Values represent the Mean + SEM for three experiments. At every time point measured, the culture with nanocarriers had 10 times higher cell densities than the cell cultures exposed to microcarriers (p < 0.006).

 

3.3 Micro and nanocarrier glucose concentrations

Glucose measurement indicated that dextran-containing nanocarriers had 59% higher glucose concentration (719 + 139 mg/L) than cellulose-containing microcarrier (411 + 22 mg/L) [p < .05]. CHO cell cultures exposed to nanoemulsions without added dextran, didn’t promote any additional cell growth (data not shown).

 

4. Discussion

Cell density in a bioreactor is correlated with biologics production such as proteins but not limited to lysosomal enzyme production (13). Microcarriers have been used to promote cell density-associated increase in biologics production (2). As dextran was incorporated into microcarriers in early days (9) before switching to cellulose, dextran-derived nanocarriers were used in the SANE-based nanocarriers for comparative purposes. Microcarriers have the advantage of [a] increasing production capacity [b] enhancing separation of cells from secreted end products [c] protecting against physical stress [d] reducing the required volume of cell culture media [e] reducing labor intensity and [f] lowering risk of contamination (2). In earlier studies, use of dextran microcarriers led to enhanced cell attachment with anchorage cells, and to increased cell density (9). Since then, a variety of microcarriers have been developed for optimization of cell culture-mediated production of biologics which has subsequently improved the quality of the microcarrier (14). However, more modifications of the microcarriers were developed to enhance cell growth such as increasing the porosity of polymers for greater cell attachment and growth, addition of cellulose and gelatin (15), collagen (16), glass, and polyethylene (17) materials. This increase in porosity provides extended surface area in the interior and additional attachment space (18) which can support higher cell concentration with an equivalent number of beads. For example, our comparative porous microcarriers which were made from cellulose (11) have an average pore diameter of approximately 30 µM (19). These pore sizes allow 14-15 µM range CHO cells to enter into this porous microcarrier (18). Dextran-derived materials have been widely used in biologic application because they [a] provide a matrix for anchorage-dependent cells to attach to [b] have a simple glucose backbone raising the possibility that functional groups can be attached for targeting purposes [c] have a neutral pH [d] are water soluble [e] are biodegradable, [f] demonstrate ease of removal by simple filtration and [g] are biocompatible (10). Thus, dextran was also included in our nanocarrier system instead of using cellulose based nanocarriers. Although both the polysaccharides, cellulose and dextran, are biosynthesized, and are made of glucose, their physical and chemical properties are different, such as, their repeating glucose units being linked together by (ß 1 4) for cellulose and (α 1 6) linkages for dextran. In addition, cellulose has two hydroxyl groups (OH) and one hydroxymethyl group (CH2OH) per glucose ring, whereas dextran has three OH groups and no CH2OH group (20). The molecular mobility in amorphous materials such as dextran and cellulose is generally attributed to localized, thermally activated motions, and it leads to macroscopic mechanical or dielectric behavior (21). In addition to these differences, dextran was selected for attaching the cell membranes instead of cellulose, since the latter also contained pores suggesting potentially different mechanism(s) of action regarding their ability to increase cell density.

 

4.1 Entrapment versus attachment

Despite having similar concentrations of polymer (75 mg) dextran for nanocarriers and 75 mg for porous cellulose-based microcarriers, our nanocarrier system has a greater surface to volume ratio by virtue of their nanoparticles having a particle size of 26 nm compared to 30 micron pores contained in the cellulose-based microcarriers (18). This means the dextran-nanocarriers have almost 1000 times higher numbers of particle than 30 micron pore size microcarriers. The finding that the dextran-containing nanocarriers had 59% higher glucose concentration than cellulose-containing microcarrier supports our hypothesis that the dextran-containing nanocarrier had higher dextran particles than cellulose-contained microcarrier. Thus the increased dextran molecules in our nanocarriers result in higher number of cell attachment than is possible for the cellulose containing microcarrier (Illustration 1). In our nanocarrier system, cells can be attached to these nanocarriers instead of being trapped within the porous microcarrier. Previous reports indicate that use of microcarriers increased cell density due to greater surface to volume ratio (22). In this communication, the greater surface-to volume ratio coupled with increased content of the polymer dextran of the nanocarriers presumably would support the attachment of more anchorage dependent cells in a given volume (up to 10 fold). This is consistent with the reported findings, that a scaffold composed of ultra-fine nanofibers provides the added benefit of improved mechanical properties and more extensive substrate for cell attachment (28). In addition, dextran containing particles are reported to have higher loading capacity and loading efficiency (29). Therefore, having outside of the micelle structure, as shown in Illustration 1, dextran particles can be attached strongly with the cell membrane. Higher cell density has been reported to be associated with higher productivity (24, 25, 27). Although we did not measure any direct relationship between cell density and productivity, our finding at days 2nd and 4th that cell cultures which were exposed to nanocarriers had significantly higher cellular protein concentration, presumably as an indicator of the production of a protein-based biologic than our controlled microcarriers would support that notion. In biomanufacturing processes, lactate measurement is one of the metabolites monitored as an indicator of increasing CHO cell densities (23, 26) Our lactate findings results indicate that media from cells exposed to our dextran nanocarriers had higher lactate concentration than microcarrier-containing cultures supporting the proposed association between increasing cell density and higher rates of metabolism. Our findings in this communication are supported by the study of Ryu (30) who showed the poly (lactic-co-glycolic acid) (PLGA) nanospheres (696nm in average diameter) promoted the enhancement of growth for anchorage-dependent animal cells to suspension culture. Their method may be useful for the mass production of recombinant proteins through large-scale suspension culture of anchorage-dependent animal cells. However, their poly (lactic-co-glycolic acid) (PLGA) nanospheres were 696nm in average diameter compared to the mean particle size of 20-30 nm for our nanocarriers. Important issues such as nanocarrier stability over the usual duration of a perfusion bioreactor produced-biologics for 30 days or more (Only 7 day duration studies were reported in this communication) could not be performed due to limitations in bioreactor availability and optimum conditions for conduction of the studies. In summary, our studies have shown that dextran-containing nanocarriers promote cell density greater than a microcarrier system. These findings are supported by (a) increased concentration of polymer of the nano vs. microcarrier (b) numbers of viable cells, (c) cell lysate protein and media accumulation of lactate of CHO cell cultures exposed to nanocarriers vs. microcarriers.

 

Illustration 1: Dextran paticles are located in and out side of Micelle Structure from SANE. Outside Hydrophilic detran paticles are attached to CHO cell membrane

 

References

  1. Lars Keld Nielsen, Bioreactors for Hematopoietic Cell Culture, Annual Review of Biomedical Engineering 1:129-152, August 1999.
  2. Microcarrier cell culture, Principles and methods, Hand book, GE health care, Ney Jersey: Amersham Biosciences Corp, 2005.
  3. Kathy Wong, Madhusudan Peshwa, Wei Hu, Overview of Microcarrier culture, Cellular Bioprocess Technology 1-8, 2004.
  4. Kwon YJ, Peng CA. Calcium-alginate gel bead cross-linked with gelatin as microcarrier for anchorage-dependent cell culture. Bio-techniques 33:212, 2002.
  5. Croughan MS, Hamel JF, Wang DIC. Hydrodynamic effects on animal cells grown in microcarrier culture. Biotechnology Bioeng 29:130–41, 1987.
  6. Inacore MS, Drapeau D, Adamson SR. Adaptation of mammalian cells to growth in serum-free media. Mol Biotechnology 15:249–57, 2000.
  7. Deyu Kong, Reiner Gentz & Junli Zhang, Development of a versatile computer integrated control system for bioprocess controls. Cytotechnology 26:3, May, 1998.
  8. Protein purification, Amersham Pharmacia Biotech, Uppsala, Sweden, 2001: www.genomics.bham.ac.uk/Documents/ProteinPurification.pdf.
  9. Levine, D.W., Wang, D.I.C. and Thilly, W.G.. Optimization of growth surface parameters in microcarrier cell culture. Biotechnology. Bioeng 21:821−845, 1979.
  10. Properties of dextran, Dextran chemistry, manufacturers of dextran, Pharmacosmos. Holbaek, Denmark.
  11. Han et al. Cultivation of Recombinant Chinese Hamster Ovary Cells Grown as Suspended Aggregates in Stirred Vessels, J Biosci Bioeng. 102, 5:430-5, 2006.
  12. Marion M. Bradford, rapid and sensitive method for the quantization of microgram quantities of protein utilizing the principle of protein-dye binding Analytical Biochemistry 72, 1-2: 248-254, May 1976.
  13. Thomas Kiy, Gerda Scheidgen-Kleyboldt, Arno Tiedtke, Production of lysosomal enzymes by continuous high-cell-density fermentation of the ciliated protozoon Tetrahymena thermophila in a perfused bioreactor, Enzyme and Microbial Technology 18, Issue 4:268-274, March 1996.
  14. C. A. M. Velden-de Groot, Microcarrier technology present status and perspective, Cytotechnology 18, 4: 51-56, 1995.
  15. Nilsson K., Buzsaky F., & Mosbach K., Growth of Anchorage−Dependent Cells on Macroporous Microcarriers, Bio/Technology 4: 989 – 990, 1986.
  16. Dean, R. C., Jr., Karkare, S. B., Phillips, P. G., Ray, N. G., and Runstadler, P. W., Jr.: Continuous cell culture with fluidized sponge beds. In Lyderson, B. K. (ed.), Large scale mammalian cell culture technology. Hanser Publications, New York, NY, 145-167, 1987.
  17. Preissmann A. Wiesmann R.Buchholz R.G. Werner R. Noé W., Investigations on oxygen limitations of adherent cells growing on macroporous microcarriers, Cytotechnology 24, 2: 121-134, 1997.
  18. Ng Y-C., Berrym J.M., Butler M.,Optimization of physical parameters for cell attachment and growth on macroporous microcarriers, Biotechnology and Bioengineering 50, 6:.627-635, 1996.
  19. L. Ikonomou,J. Drugmand,G.Bastin,Y. Schneider,S. Agathos,Microcarrier Culture of Lepidopteran Cell Lines: Implications for Growth and Recombinant Protein Production, Biotechnology Progress 18, 6:1345-1355, 2002.
  20. D. Kong, M. Chen, R. Gentz,J. Zhang, Cell growth and protein formation on various microcarriers, Cytotechnology 29, 2:151-158, 1999.
  21. De La Rosa A., Heux L., Cavaille J.Y. Secondary relaxations in poly (allyl-alcohol), PAA, and poly (vinyl alcohol), PVA: Part I. mechanical relaxations compared with mechanical behavior of cellulose and dextran in the presence of polar solvent Polymer 41, 20: 7547-7557, 2000.
  22. Montagnon B.J., Polio and rabies vaccines produced in continuous cell lines: a reality Vero cell line. Dev. Biol. Stand 70 : 27-42, 1989.
  23. Zhang, Yuan-Xing, Sun, Xiang-Ming, Estimation of Chinese hamster ovary cell density in packed-bed bioreactor by lactate production rate, Biotechnology Letters 24,11:853-857, ,2003.
  24. Wurm FM Production of recombinant protein therapeutics in cultivated mammalian cells. Nat Biotechnology 22:1393–1398, 2004.
  25. J.Yang, A. Angelillo, M. Chaudhry, C. Goldenberg, Achievement of high cell density and high antibody productivity by a controlled-fed perfusion bioreactor process, Biotechnology and Bioengineering 69,1:74-82, 2000.
  26. Tsao, Y., Cardoso, A. G., Condon, R. G. G., et al. Monitoring Chinese hamster ovary cell culture by the analysis of glucose and lactate metabolism, 2005.
  27. A. Ayed, I.Rabhi, K.Dellagi, H.Kallel, High level production and purification of human interferon [alpha]2b in high cell density culture of Pichia pastoris, Enzyme and Microbial Technology 42,2:173-180, 2008.
  28. W.J. Li, R. Tuli, X. Huang, P. Laquerriere and R.S. Tuan, Multilineage differentiation of human mesenchymal stem cells in a three-dimensional nanofibrous scaffold, Biomaterials 26:5158–5166, 2005.
  29. Liu Z, Cheung R, Wu XY, Ballinger JR, Bendayan R, Rauth AM., A study of doxorubicin loading onto and release from sulfopropyl dextran ion-exchange microspheres, J Control Release.77,3:213-24 2001 Dec 13.
  30. Ryu J.H., HEK 293 cell suspension culture using fibronectin-adsorbed polymer nanocarriers in serum-free medium, Journal of Biomedical Materials Research 71A,1:128-133, 2004.

 

Copyright: (c) 2012 E. Anton, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Nano Biomedicine and Engineering.

Copyright © Shanghai Jiao Tong University Press